AGIO
Price
$36.01
Change
-$0.12 (-0.33%)
Updated
Sep 5 closing price
Capitalization
2.09B
52 days until earnings call
TLSA
Price
$1.66
Change
+$0.08 (+5.06%)
Updated
Sep 5 closing price
Capitalization
193.97M
Interact to see
Advertisement

AGIO vs TLSA

Header iconAGIO vs TLSA Comparison
Open Charts AGIO vs TLSABanner chart's image
Agios Pharmaceuticals
Price$36.01
Change-$0.12 (-0.33%)
Volume$1.48M
Capitalization2.09B
Tiziana Life Sciences
Price$1.66
Change+$0.08 (+5.06%)
Volume$393.68K
Capitalization193.97M
AGIO vs TLSA Comparison Chart in %
Loading...
AGIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TLSA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AGIO vs. TLSA commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AGIO is a Hold and TLSA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 08, 2025
Stock price -- (AGIO: $36.01 vs. TLSA: $1.66)
Brand notoriety: AGIO and TLSA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AGIO: 168% vs. TLSA: 108%
Market capitalization -- AGIO: $2.09B vs. TLSA: $193.97M
AGIO [@Biotechnology] is valued at $2.09B. TLSA’s [@Biotechnology] market capitalization is $193.97M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AGIO’s FA Score shows that 1 FA rating(s) are green whileTLSA’s FA Score has 0 green FA rating(s).

  • AGIO’s FA Score: 1 green, 4 red.
  • TLSA’s FA Score: 0 green, 5 red.
According to our system of comparison, AGIO is a better buy in the long-term than TLSA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AGIO’s TA Score shows that 4 TA indicator(s) are bullish while TLSA’s TA Score has 3 bullish TA indicator(s).

  • AGIO’s TA Score: 4 bullish, 6 bearish.
  • TLSA’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, AGIO is a better buy in the short-term than TLSA.

Price Growth

AGIO (@Biotechnology) experienced а -4.51% price change this week, while TLSA (@Biotechnology) price change was -8.29% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.48%, and the average quarterly price growth was +31.71%.

Reported Earning Dates

AGIO is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AGIO($2.09B) has a higher market cap than TLSA($194M). TLSA YTD gains are higher at: 138.437 vs. AGIO (9.586). TLSA has higher annual earnings (EBITDA): -17.14M vs. AGIO (-456.28M). AGIO has more cash in the bank: 939M vs. TLSA (201K). TLSA has less debt than AGIO: TLSA (247K) vs AGIO (48.8M). AGIO has higher revenues than TLSA: AGIO (40.9M) vs TLSA (0).
AGIOTLSAAGIO / TLSA
Capitalization2.09B194M1,078%
EBITDA-456.28M-17.14M2,663%
Gain YTD9.586138.4377%
P/E Ratio3.19N/A-
Revenue40.9M0-
Total Cash939M201K467,164%
Total Debt48.8M247K19,757%
FUNDAMENTALS RATINGS
AGIO vs TLSA: Fundamental Ratings
AGIO
TLSA
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
37
Fair valued
85
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
1799
PRICE GROWTH RATING
1..100
6055
P/E GROWTH RATING
1..100
74100
SEASONALITY SCORE
1..100
8540

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AGIO's Valuation (37) in the Biotechnology industry is somewhat better than the same rating for TLSA (85). This means that AGIO’s stock grew somewhat faster than TLSA’s over the last 12 months.

AGIO's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as TLSA (100). This means that AGIO’s stock grew similarly to TLSA’s over the last 12 months.

AGIO's SMR Rating (17) in the Biotechnology industry is significantly better than the same rating for TLSA (99). This means that AGIO’s stock grew significantly faster than TLSA’s over the last 12 months.

TLSA's Price Growth Rating (55) in the Biotechnology industry is in the same range as AGIO (60). This means that TLSA’s stock grew similarly to AGIO’s over the last 12 months.

AGIO's P/E Growth Rating (74) in the Biotechnology industry is in the same range as TLSA (100). This means that AGIO’s stock grew similarly to TLSA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AGIOTLSA
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
77%
Bullish Trend 4 days ago
79%
Momentum
ODDS (%)
Bearish Trend 4 days ago
74%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bearish Trend 4 days ago
76%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
74%
Bearish Trend 4 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
74%
Bearish Trend 4 days ago
90%
Advances
ODDS (%)
Bullish Trend 6 days ago
77%
Bullish Trend 18 days ago
82%
Declines
ODDS (%)
Bearish Trend 4 days ago
74%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
74%
Bullish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 4 days ago
77%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
AGIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TLSA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MZDAF7.660.50
+6.98%
Mazda Motor Corp.
AVIFY9.94N/A
N/A
Advanced Info Service Public Co., Ltd.
AVNBF25.06N/A
N/A
AVON TECHNOLOGIES PLC
FWFW0.17N/A
N/A
Flywheel Advanced Technology Inc.
LDXHF0.09-0.01
-9.52%
LUMOS DIAGNOSTICS HLDGS LTD